Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?
Strata shares jumped about 63% in pre-market trading on Oct. 14, 2025, after the company announced a clinical case study showing its XTRAC laser nearly cleared lesions of a rare skin lymphoma. The stock, which closed at $1.54 on Oct. 13, spiked into the mid-$2 range in extended hours. Trading volume surged to 45.6 million shares, far above the 6 million average.
